<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00776035</url>
  </required_header>
  <id_info>
    <org_study_id>07-1128</org_study_id>
    <nct_id>NCT00776035</nct_id>
  </id_info>
  <brief_title>Sex and Obesity: Effects on Heart Failure Study</brief_title>
  <official_title>Sex and Obesity Effects on Myocardial Blood Flow and Metabolism</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Washington University School of Medicine</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Barnes-Jewish Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Washington University School of Medicine</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Sex has a major impact on myocardial metabolism and blood flow. In subjects without heart
      failure men's hearts tend to use proportionally more glucose and women's hearts use more fat
      and have higher blood flow.

      Obesity is a major risk factor for Heart Failure. In subjects without heart failure,
      increasing body mass index is predictive of increased blood flow and fatty acid metabolism in
      women, but not men.

      To measure blood flow and metabolism we will be using radioactive materials and a PET
      (positron emission Tomography)scan to study the metabolism of the heart.

      Hypotheses: 1) Women with nonischemic heart failure will have higher levels of heart blood
      flow and fatty acid metabolism and lower glucose metabolism rates than men with nonischemic
      heart failure 2) Patients with obesity-related HF have a myocardial metabolic profile that is
      similar to that of obese subjects without heart failure and different (higher FA metabolism)
      from that of nonobese Heart failure patients.
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>January 2008</start_date>
  <completion_date type="Anticipated">February 2019</completion_date>
  <primary_completion_date type="Anticipated">February 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Myocardial blood flow, glucose metabolism, oxygen metabolism, and fat metabolism</measure>
    <time_frame>the time frame of the study</time_frame>
    <description>The heart uses sugars, fats, oxygen to make its energy for function.</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">10</enrollment>
  <condition>Obesity</condition>
  <condition>Heart Failure</condition>
  <arm_group>
    <arm_group_label>heart failure</arm_group_label>
    <description>Obesity related Heart failure population</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>PET (positron Emission Tomography)</intervention_name>
    <description>this is a diagnostic scan that requires the injection of radioactive tracers into an IV placed in the arm.</description>
    <arm_group_label>heart failure</arm_group_label>
    <other_name>PET scan</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Echocardiogram</intervention_name>
    <description>an ultrasound of the heart</description>
    <arm_group_label>heart failure</arm_group_label>
    <other_name>Echo</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>VO2 peak test</intervention_name>
    <description>walking on a treadmill during which you will breath in and out through a tube</description>
    <arm_group_label>heart failure</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Body composition Study</intervention_name>
    <description>a scan of your entire body measuring Body Mass Index, fat percentage etc...</description>
    <arm_group_label>heart failure</arm_group_label>
    <other_name>DEXA scan</other_name>
  </intervention>
  <intervention>
    <intervention_type>Radiation</intervention_type>
    <intervention_name>15O water</intervention_name>
    <description>radioactive tracer used to study blood flow during the PET scan</description>
    <arm_group_label>heart failure</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Radiation</intervention_type>
    <intervention_name>11C Acetate</intervention_name>
    <description>radioactive tracer that helps study heart metabolism</description>
    <arm_group_label>heart failure</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Radiation</intervention_type>
    <intervention_name>11C Palmitate</intervention_name>
    <description>radioactive tracer used to study fatty acid usage in the heart</description>
    <arm_group_label>heart failure</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Radiation</intervention_type>
    <intervention_name>11C Glucose</intervention_name>
    <description>radioactive tracer usde to study glucose usage in the heart</description>
    <arm_group_label>heart failure</arm_group_label>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Non diagnostic genetic samples
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        obesity related heart failure patients
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria: men and women

          -  Non Ischemic Heart failure, ejection fraction &lt;40%, premenopausal, Obese(BMI
             &gt;30),Lean, age 20-50, non diabetic

        Exclusion Criteria:

          -  Pregnancy, lactating, actively losing weight, nonsedentary, greater than Class I
             hypertension,require alterations in heart medications, Diabetics.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Linda Peterson, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Washington University School of Medicine</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Washington University School of Medicine</name>
      <address>
        <city>St Louis</city>
        <state>Missouri</state>
        <zip>63110</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Essop MF, Opie LH. Metabolic therapy for heart failure. Eur Heart J. 2004 Oct;25(20):1765-8.</citation>
    <PMID>15474689</PMID>
  </reference>
  <reference>
    <citation>Taegtmeyer H, Salazar R. Myocardial metabolism: a new target for the treatment of heart disease? Curr Hypertens Rep. 2004 Dec;6(6):414-5.</citation>
    <PMID>15527683</PMID>
  </reference>
  <reference>
    <citation>Stanley WC, Recchia FA, Lopaschuk GD. Myocardial substrate metabolism in the normal and failing heart. Physiol Rev. 2005 Jul;85(3):1093-129. Review.</citation>
    <PMID>15987803</PMID>
  </reference>
  <reference>
    <citation>Kenchaiah S, Evans JC, Levy D, Wilson PW, Benjamin EJ, Larson MG, Kannel WB, Vasan RS. Obesity and the risk of heart failure. N Engl J Med. 2002 Aug 1;347(5):305-13.</citation>
    <PMID>12151467</PMID>
  </reference>
  <reference>
    <citation>Peterson LR, Herrero P, Schechtman KB, Racette SB, Waggoner AD, Kisrieva-Ware Z, Dence C, Klein S, Marsala J, Meyer T, Gropler RJ. Effect of obesity and insulin resistance on myocardial substrate metabolism and efficiency in young women. Circulation. 2004 May 11;109(18):2191-6. Epub 2004 May 3.</citation>
    <PMID>15123530</PMID>
  </reference>
  <reference>
    <citation>Kates AM, Herrero P, Dence C, Soto P, Srinivasan M, Delano DG, Ehsani A, Gropler RJ. Impact of aging on substrate metabolism by the human heart. J Am Coll Cardiol. 2003 Jan 15;41(2):293-9.</citation>
    <PMID>12535825</PMID>
  </reference>
  <reference>
    <citation>Peterson LR, Soto PF, Herrero P, Schechtman KB, Dence C, Gropler RJ. Sex differences in myocardial oxygen and glucose metabolism. J Nucl Cardiol. 2007 Jul;14(4):573-81. Epub 2007 Jun 27.</citation>
    <PMID>17679067</PMID>
  </reference>
  <reference>
    <citation>Dávila-Román VG, Vedala G, Herrero P, de las Fuentes L, Rogers JG, Kelly DP, Gropler RJ. Altered myocardial fatty acid and glucose metabolism in idiopathic dilated cardiomyopathy. J Am Coll Cardiol. 2002 Jul 17;40(2):271-7.</citation>
    <PMID>12106931</PMID>
  </reference>
  <verification_date>March 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 17, 2008</study_first_submitted>
  <study_first_submitted_qc>October 17, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 20, 2008</study_first_posted>
  <last_update_submitted>March 28, 2017</last_update_submitted>
  <last_update_submitted_qc>March 28, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">March 30, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Obesity</keyword>
  <keyword>Heart</keyword>
  <keyword>Failure</keyword>
  <keyword>PET</keyword>
  <keyword>radiation</keyword>
  <keyword>metabolism</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Obesity</mesh_term>
    <mesh_term>Heart Failure</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

